Businesses for Sale

Operating from an ISO 13485-certified facility with sterilization capabilities, this company develops and manufactures next generation implants that are transforming complex reconstructive and aesthetic procedures worldwide. Built around a comprehensive portfolio of more than 44 granted patents spanning 16 families, the company’s products are becoming a preferred choice for CMF and aesthetic procedures among surgeons worldwide because they are highly customizable allowing for intra-operative adjustments with ease and precision. Its products, distinguished by superior quality and industry leading infection and rejection rates, are approved for use in more than 35 countries, including the EU with an MDP certification, this company is perfectly positioned to overtake legacy products that dominate an estimated 18-billion-dollar market.

INVESTMENT HIGHLIGHTS:

✔ Profitable & Growing: Revenue has grown steadily, with historical gross margins in the low-to-mid 90% range and a growing top line.
✔ Diversified Customer Base: Products approved for use in more than 35 countries, with no reliance on a single customer.
✔ Protected Product Line: A portfolio of 45+ patents issued/pending helps protect the Company's differentiated technology from being easily replicated.
✔ Strong Surgeon Support: Highly customizable implants preferred by surgeons worldwide, allowing intra-operative adjustments with ease and precision.
✔ Experienced, Committed Team: 18 people in place covering all facets of the operation are expected to stay on, supporting a smooth ownership transition.

GROWTH OPPORTUNITIES:

• Sales and Marketing Investment: Focused primarily on innovation, the Company spends less than 5% annually on marketing and advertising — meaningful room for a new owner to invest further in growth.
• Contract Manufacturing Potential: ISO 13485-certified manufacturing facility with sterilization capabilities with room to expand into adjacent square footage opens up opportunity to add additional product lines.